Atipamezole (brand name Antisedan Pfizer) is a synthetic alpha2-adrenergic antagonist indicated for the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs. It has also been researched in humans as a potential anti-Parkinsonian drug.
This page contains content from the copyrighted Wikipedia article "Atipamezole"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
